VCEL
Vericel Corporation NASDAQ Listed Feb 4, 1997$35.13
Mkt Cap $1.8B
52w Low $28.95
36.3% of range
52w High $45.97
50d MA $33.98
200d MA $35.69
P/E (TTM)
107.8x
EV/EBITDA
60.1x
P/B
5.1x
Debt/Equity
0.3x
ROE
4.7%
P/FCF
73.6x
RSI (14)
—
ATR (14)
—
Beta
1.21
50d MA
$33.98
200d MA
$35.69
Avg Volume
592.6K
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
64 Sidney Street · Cambridge, MA 02139 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 36.78 | +10.1% | -4.5% | — | — | — | — | — |
| Feb 26, 2026 | AMC | 0.45 | 0.45 | +0.0% | 37.68 | -2.7% | -5.3% | -6.2% | -8.7% | -7.2% | -9.8% | — |
| Nov 6, 2025 | AMC | -0.02 | 0.10 | +600.0% | 38.75 | +0.9% | +0.5% | +0.6% | +5.9% | +4.4% | +2.8% | — |
| Jul 31, 2025 | AMC | -0.04 | -0.01 | +75.0% | 34.94 | -1.6% | +2.0% | +7.6% | +5.4% | +3.9% | +3.5% | — |
| May 8, 2025 | AMC | -0.09 | -0.23 | -155.6% | 41.87 | -0.2% | -0.3% | +1.9% | +4.2% | +1.0% | -0.9% | — |
| Feb 27, 2025 | AMC | 0.31 | 0.38 | +22.6% | 49.62 | +0.0% | +3.4% | -0.2% | +3.1% | +3.8% | -1.7% | — |
| Nov 7, 2024 | AMC | -0.05 | -0.02 | +60.0% | 50.03 | -1.0% | +7.9% | +13.5% | +11.7% | +10.9% | +5.4% | — |
| Aug 1, 2024 | AMC | -0.10 | -0.10 | +0.0% | 47.52 | -1.2% | +0.2% | -3.5% | -1.6% | -4.7% | -2.7% | — |
| May 8, 2024 | AMC | -0.11 | -0.08 | +27.3% | 47.69 | +0.3% | +2.0% | +0.9% | +1.7% | +1.8% | +3.6% | — |
| Feb 29, 2024 | AMC | 0.17 | 0.26 | +52.9% | 45.68 | +1.6% | -2.1% | -2.0% | -2.7% | -1.1% | -1.9% | — |
| Nov 8, 2023 | AMC | -0.13 | -0.08 | +38.5% | 35.27 | +0.3% | -8.1% | -3.9% | -3.7% | +4.2% | +2.2% | — |
| Aug 2, 2023 | AMC | -0.13 | -0.11 | +15.4% | 34.63 | +0.9% | -7.7% | -7.6% | -7.9% | -5.3% | -7.1% | — |
| May 10, 2023 | AMC | -0.13 | -0.16 | -23.1% | 34.19 | +0.7% | -3.5% | -4.1% | -1.3% | -3.3% | -3.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Truist | Maintains | Buy → Buy | — | $35.14 | $34.89 | -0.7% | +0.7% | -3.9% | +1.5% | +1.9% | -4.2% |
| Feb 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.68 | $36.66 | -2.7% | -5.3% | -6.2% | -8.7% | -7.2% | -9.8% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $36.40 | $36.40 | +0.0% | -0.7% | -1.0% | +2.7% | +2.7% | +3.2% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $38.94 | $39.71 | +2.0% | +0.1% | +5.4% | +3.9% | +2.3% | +2.4% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $34.64 | $34.23 | -1.2% | -3.0% | +0.3% | +2.0% | +4.0% | +5.2% |
| Sep 17 | BTIG | Downgrade | Buy → Neutral | — | $33.23 | $31.85 | -4.2% | -9.7% | -4.2% | -4.7% | -4.3% | -6.1% |
| Aug 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.94 | $34.38 | -1.6% | +2.0% | +7.6% | +5.4% | +3.9% | +3.5% |
| Jun 16 | Stephens & Co. | Maintains | Overweight → Overweight | — | $42.67 | $43.03 | +0.8% | -2.5% | -2.7% | -2.1% | -1.5% | -2.0% |
| May 22 | Stephens & Co. | Maintains | Overweight → Overweight | — | $41.07 | $40.74 | -0.8% | +0.8% | -0.4% | +2.4% | +2.5% | +0.7% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $41.90 | $41.33 | -1.4% | -1.6% | -1.6% | +0.3% | -2.6% | -1.6% |
| Mar 3 | Truist | Maintains | Buy → Buy | — | $51.29 | $51.20 | -0.2% | -3.5% | -0.3% | +0.5% | -4.9% | -3.4% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $49.62 | $49.63 | +0.0% | +3.4% | -0.2% | +3.1% | +3.8% | -1.7% |
| Feb 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.54 | $58.25 | -0.5% | +0.9% | +1.5% | +5.6% | +2.0% | -0.3% |
| Jan 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $58.67 | $55.09 | -6.1% | -1.9% | -4.0% | +0.7% | +1.5% | -0.2% |
| Jan 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $58.67 | $55.09 | -6.1% | -1.9% | -4.0% | +0.7% | +1.5% | -0.2% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $56.69 | $57.07 | +0.7% | -0.8% | -3.1% | -0.3% | +0.6% | +1.1% |
| Nov 26 | BTIG | Maintains | Buy → Buy | — | $58.62 | $58.40 | -0.4% | +0.2% | -1.5% | -0.8% | +0.2% | -0.6% |
| Nov 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $52.89 | $52.68 | -0.4% | +5.6% | +8.3% | +7.2% | +11.8% | +10.8% |
| Nov 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $50.03 | $49.54 | -1.0% | +7.9% | +13.5% | +11.7% | +10.9% | +5.4% |
| Aug 27 | TD Cowen | Maintains | Buy → Buy | — | $49.94 | $49.85 | -0.2% | +7.2% | +5.3% | +3.2% | +3.4% | -1.8% |
| Aug 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $47.52 | $46.97 | -1.2% | +0.2% | -3.5% | -1.6% | -4.7% | -2.7% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.52 | $46.97 | -1.2% | +0.2% | -3.5% | -1.6% | -4.7% | -2.7% |
| Jul 16 | Truist | Maintains | Buy → Buy | — | $49.85 | $50.66 | +1.6% | +4.8% | +3.8% | +2.8% | +0.5% | +3.5% |
| Jul 15 | BTIG | Maintains | Buy → Buy | — | $48.50 | $48.63 | +0.3% | +2.8% | +7.7% | +6.6% | +5.6% | +3.3% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.69 | $47.83 | +0.3% | +2.0% | +0.9% | +1.7% | +1.8% | +3.6% |
| Mar 26 | Truist | Maintains | Buy → Buy | — | $47.94 | $48.13 | +0.4% | +3.4% | +9.2% | +8.5% | +10.3% | +6.9% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $45.68 | $46.43 | +1.6% | -2.1% | -2.0% | -2.7% | -1.1% | -1.9% |
| Mar 1 | Truist | Maintains | Buy → Buy | — | $45.68 | $46.43 | +1.6% | -2.1% | -2.0% | -2.7% | -1.1% | -1.9% |
| Jan 25 | Truist | Upgrade | Hold → Buy | — | $40.82 | $43.41 | +6.3% | +4.4% | +4.4% | +9.2% | +8.4% | +5.3% |
| Jan 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.24 | $38.39 | +0.4% | +2.5% | -1.1% | +2.4% | +3.7% | +9.9% |
| Nov 9 | Truist | Maintains | Hold → Hold | — | $35.27 | $35.39 | +0.3% | -8.1% | -3.9% | -3.7% | +4.2% | +2.2% |
| Sep 21 | Stephens & Co. | Maintains | Overweight → Overweight | — | $32.52 | $33.26 | +2.3% | +5.1% | +4.6% | +4.6% | +3.0% | +9.2% |
| Sep 21 | Truist | Maintains | Hold → Hold | — | $32.52 | $33.26 | +2.3% | +5.1% | +4.6% | +4.6% | +3.0% | +9.2% |
| Sep 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.52 | $33.26 | +2.3% | +5.1% | +4.6% | +4.6% | +3.0% | +9.2% |
| Aug 8 | BTIG | Upgrade | Neutral → Buy | — | $31.90 | $33.22 | +4.1% | +2.8% | +0.8% | -0.1% | -0.7% | +0.8% |
| Aug 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.63 | $34.95 | +0.9% | -7.7% | -7.6% | -7.9% | -5.3% | -7.1% |
| Aug 3 | Truist | Maintains | Hold → Hold | — | $34.63 | $34.95 | +0.9% | -7.7% | -7.6% | -7.9% | -5.3% | -7.1% |
| Jul 19 | Truist | Maintains | Hold → Hold | — | $38.87 | $39.06 | +0.5% | +1.0% | -1.5% | -0.4% | -1.2% | -3.8% |
| May 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $34.19 | $34.44 | +0.7% | -3.5% | -4.1% | -1.3% | -3.3% | -3.9% |
| May 11 | Truist | Maintains | Hold → Hold | — | $34.19 | $34.44 | +0.7% | -3.5% | -4.1% | -1.3% | -3.3% | -3.9% |
| Feb 27 | Truist | Maintains | Hold → Hold | — | $30.50 | $30.82 | +1.0% | +0.6% | -0.3% | -1.7% | -0.9% | +2.7% |
| Jan 31 | Truist | Maintains | Hold → Hold | — | $27.03 | $27.03 | +0.0% | +1.6% | +5.0% | +15.9% | +14.9% | +13.2% |
| Jan 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $27.85 | $27.83 | -0.1% | +2.4% | -2.9% | -1.4% | +1.9% | +12.5% |
| Jan 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.34 | $26.60 | +1.0% | -4.6% | -3.2% | -7.1% | -9.3% | -9.5% |
| Dec 20 | Truist | Maintains | Hold → Hold | — | $22.84 | $22.89 | +0.2% | +4.5% | +8.1% | +6.9% | +4.3% | +3.1% |
| Nov 10 | BTIG | Downgrade | Buy → Neutral | — | $17.65 | $17.39 | -1.5% | +27.0% | +34.8% | +30.8% | +31.9% | +27.0% |
| Nov 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $17.65 | $17.39 | -1.5% | +27.0% | +34.8% | +30.8% | +31.9% | +27.0% |
| Jul 18 | BTIG | Maintains | Buy → Buy | — | $27.54 | $27.74 | +0.7% | -1.1% | +2.6% | +2.2% | +4.0% | +2.5% |
| Feb 25 | SVB Leerink | Maintains | Outperform → Outperform | — | $38.88 | $38.60 | -0.7% | +0.9% | +6.0% | +4.6% | +11.3% | +4.9% |
| Dec 21 | Truist | Maintains | Buy → Buy | — | $38.30 | $38.39 | +0.2% | +4.0% | +5.7% | +8.7% | +9.6% | +5.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 5,000 | $40.50 | $202K | 21,009 | — | — |
| May 7, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,422 | $40.50 | $58K | 1,118 | — | — |
| May 6, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,433 | $38.00 | $130K | 2,540 | — | — |
Data updated apr 27, 2026 7:24am
· Source: massive.com